High cognitive reserve postpones dementia onset in older adults with cardiometabolic disease Authors: Abigail Dove, Wenzhe Yang, Serhiy Dekhtyar, Jie Guo, Jiao Wang, Anna Marseglia, Davide Liborio Vetrano, Rachel A Whitmer, Weili Xu Published: 2025 ABSTRACT AbstractBackgroundCardiometabolic diseases (CMDs) including type 2 diabetes, heart disease, and stroke have been linked to increased dementia risk. We examined whether high levels of cognitive reserve (CR) are associated with an attenuation in the CMD‐dementia association and lower levels of CMD‐related brain pathologies.MethodWithin the UK Biobank, 216,178 dementia‐free participants aged ≥60 were followed for up to 15 years for incident dementia via linage to medical records. At baseline, CMDs were ascertained from medical records and self‐reported medical history. Latent class analysis was used to generate an indicator of cognitive reserve (CR; low, moderate, and high) based on education, occupational attainment, confiding in others, social contact, leisure activities, and television watching time. A subsample (n = 13,663) underwent brain magnetic resonance imaging (MRI) scans 9 years after baseline. Volumes of total gray matter (GMV), hippocampus (HV), and white matter hyperintensities (WMHV) were ascertained, and mean diffusivity (MD) and fractional anisotropy (FA) in white matter tracts were collected through diffusion tensor imaging.ResultCMDs were associated with 57% increased risk of dementia (HR 1.57 [95% CI 1.48, 1.67]). In joint effect analysis, dementia risk was 35% lower among people with CMDs and moderate‐to‐high CR (HR 1.78 [1.66, 1.91]) compared to low CR (HR 2.13 [1.97, 2.30]) (reference: CMD‐free, moderate‐to‐high CR). Having moderate‐to‐high compared to low CR significantly attenuated the association between CMDs and lower GMV and HV.ConclusionModerate‐to‐high cognitive reserve may partially mitigate CMD‐related dementia risk. Resistance to neurodegeneration may account for this alleviating effect.